Page last updated: 2024-08-23

atracurium and phenytoin

atracurium has been researched along with phenytoin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Diaz, J; Matteo, RS; Ornstein, E; Schwartz, AE; Silverberg, PA; Young, WL1
Bevan, JC; Hickey, DR; Sangwan, S1
Bickler, PE; Cardone, C; Szenohradszky, J; Yost, S1
Boudreault, D; Bouthilier, A; Chouinard, P; Couture, J; Girard, DC; Girard, F; Moumdjian, R; Richard, A; Ruel, M; Varin, F1

Reviews

1 review(s) available for atracurium and phenytoin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for atracurium and phenytoin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Anesthesiology, 1987, Volume: 67, Issue:2

    Topics: Adult; Anesthesia; Atracurium; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Female; Halothane; Humans; Male; Neuromuscular Blocking Agents; Neuromuscular Junction; Phenytoin; Vecuronium Bromide

1987
Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient.
    Anaesthesia, 1988, Volume: 43, Issue:9

    Topics: Adolescent; Atracurium; Brain Neoplasms; Drug Interactions; Drug Tolerance; Epilepsy; Humans; Infusions, Intravenous; Male; Pancuronium; Parietal Lobe; Phenytoin

1988
Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity.
    Anesthesiology, 1994, Volume: 80, Issue:5

    Topics: Acetylcholine; Anesthesia, General; Animals; Atracurium; Brain; Calcium; Convulsants; Dose-Response Relationship, Drug; Enflurane; Female; Glutamates; Glutamic Acid; In Vitro Techniques; Isoquinolines; Kainic Acid; Male; N-Methylaspartate; Neuromuscular Nondepolarizing Agents; Neurotoxins; Nicotine; Pancuronium; Phenytoin; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tubocurarine; Vecuronium Bromide

1994
Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients.
    Anesthesia and analgesia, 2005, Volume: 100, Issue:2

    Topics: Adolescent; Adult; Aged; Anesthesia, General; Anticonvulsants; Atracurium; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Electric Stimulation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Monitoring, Intraoperative; Nerve Block; Neuromuscular Nondepolarizing Agents; Neurosurgical Procedures; Phenytoin; Synaptic Transmission

2005